Eliquis is a blood thinner prescribed to prevent blood clots, however it can cause uncontrollable bleeding, with no antidote.
The drug is used to prevent stroke in people with a heart rhythm disorder (atrial fibrillation) and is also prescribed after hip or knee replacement surgery to prevent a type of blood clot that can lead to future clots in the lungs.
Eliquis was introduced by Bristol-Myers Squibb and Pfizer in 2012 and marketed as a safer alternative to older blood-thinning medications like Warfarin. However, not soon after it hit the market, the drug’s approval process was scrutinized for using flawed study groups to claim the drug was safe. The study had inaccurate and missing data, failed to report adverse effects of the drug – including death, as well as other mishandlings. Eliquis lawsuits claim that the manufacturers committed fraud when setting up this clinical study.
In addition to fraud, lawsuits claim Bristol-Meyers Squibb and Pfizer failed to warn of risks associated with the drug, falsely claimed the drug is safe and acted negligently. Victims seek compensation for pain, suffering, medical expenses and other economic losses.
Other blood thinners including Xarelto and Pradaxa have faced litigation due to the improper warnings of their dangerous side effects including uncontrollable bleeding. The first Eliquis lawsuit was filed in July 2015, and it is very likely that many more will follow.
If blood-thinning drug, Eliquis, has negatively impacted you or someone you know, contact Roberts & Roberts for a free, no obligation consultation today.